2 J. Pharmacy & L. 15 (1993)
Scientific Misconduct: A Form of White Coat Crime

handle is hein.journals/jpharm2 and id is 23 raw text is: SCIENTIFIC MISCONDUCT: A FORM OF WHITE COAT
CRIME
BY SANDY KLINE*
I. INTRODUCTION
The expenditures devoted to the health care industry in the United
States have grown faster than expenditures for other types of goods
and services.' Never before has technology and new drug development
been as productive as it is today.2 Along with such growth comes
increased pressures within the scientific community to do more, faster.
Of course, in these economically challenged times, one must do so,
and with fewer resources as a form of health care cost containment
and reform.3 Increased competition for shrinking grant dollars and
the never ending burden to publish or perish within the academic
setting has pushed some researchers to cross the line and commit
scientific misconduct.4
The question becomes: what price is society willing to pay for
such advancements? Does any degree of patient morbidity associated
with such misconduct constitute a reasonable risk? This paper will
address the need to impose the currently available criminal sanctions
upon those researchers guilty of scientific misconduct as a means to
deter future misconduct and contain the spread of white coat crime.
H. DEFINING MISCONDUCT, CONTRASTING MISTAKE
Scientific misconduct or fraud in scientific research has been perceived
and defined differently over the last few years by various scientific,
* Sandra S. Kline, Pharm.D., Pharmacy Clinical Coordinator, Medical College Hos-
pitals.
1. Patricia A. Ensor, Projecting Future Drug Expenditures - 1992, 49 AM J. HosprrAL
PHARmACY 140, 145, 839 (1992)
2. See Joseph A. DiMasi et al., New Drug Development in the United States From
1963 to 1990, 50 CLINICAL PHARLAcoLoGy & THERAPEUTICS 471 (1991).
3. Philip R. Lee et al., Costs and Coverage: Pressure Toward Health Care Reform,
157 W. J. MED. 576 (1992); Jay Rockefeller, Health Care Reform: Prospects and Progress, 67
ACADEwMC MED. 141, 142 (1992).
4. See Richard Knox, The Harvard Fraud Case: Where Does the Problem Lie?, 249
JAMA 1797 (1983). The article describes a case of scientific misconduct at the Harvard Medical
School in which a research fellow, John Roland Darsee, M.D., falsified animal research
experiments and fabricated data in at least five Harvard research projects. Results of this data
was published in nine papers he co-authored, as well as many abstracts, published and unpub-
lished. The fabricated data played a major role in ultimately ruining a multicenter cooperative
-study done under contract for approximately $700,000 with the National Heart, Lung and
Blood Institute. Much of Darsee's previous work at Emory University, as well as the under-
graduate projects he was involved with, is also under suspicion.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing nearly 2,700 academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline with pricing starting as low as $29.95

Access to this content requires a subscription. Please visit the following page to request a quote or trial:

Already a HeinOnline Subscriber?